Glaxo execs at centre of drugs bribery storm
Executives of pharmaceutical supplier GlaxoSmithKline have been accused by Chinese officials of conducting a large, long-running bribery campaign to persuade doctors to prescribe drugs.
GSK employees are accused of paying "large bribes" laundered through travel agencies to doctors, hospitals and others "to open new sales channels and increase drug revenues," said a public security ministry announcement.
They also are suspected of tax offences involving collusion with travel agencies to issue false invoices, the ministry said.
GSK said it would co-operate with the authorities, but said the announcement was the first official communication it has received about the investigation.
"Corruption has no place in our business," said a company statement.